prednisolone has been researched along with Osteolysis in 15 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with lenalidomide, as the final therapeutic option, resolved the intractable melena and improved both the intestinal lesions and myeloma." | 5.39 | Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis. ( Aoki, K; Arima, H; Imai, H; Ishikawa, T; Kato, A; Matsushita, A; Mori, M; Nagano, S; Ono, Y; Tabata, S; Takahashi, T; Takiuchi, Y; Yanagita, S, 2013) |
| "In most cases multiple myeloma is an incurable plasma cell malignancy." | 2.43 | Current treatment options for myeloma. ( Dimopoulos, MA; Rahemtulla, A; Terpos, E, 2005) |
| "Infantile myofibromatosis is the most common fibrous tumor of infancy." | 2.42 | Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy. ( Gandhi, MM; Levitt, GA; Nathan, PC; Weitzman, S, 2003) |
| "Prednisolone treatment caused an appreciable decrease in calcium levels both in the bone and serum and also in bone dry weight, BMC, and BMD in rats." | 1.40 | Moderate zinc supplementation during prolonged steroid therapy exacerbates bone loss in rats. ( Bansal, SC; Dhawan, DK; Kamal, R; Khandelwal, N; Rai, DV, 2014) |
| "Treatment with lenalidomide, as the final therapeutic option, resolved the intractable melena and improved both the intestinal lesions and myeloma." | 1.39 | Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis. ( Aoki, K; Arima, H; Imai, H; Ishikawa, T; Kato, A; Matsushita, A; Mori, M; Nagano, S; Ono, Y; Tabata, S; Takahashi, T; Takiuchi, Y; Yanagita, S, 2013) |
| "2." | 1.30 | [Clinical aspects of the osteolytic (inflammatory) phase of cochlear otosclerosis]. ( Arnold, W; Kau, R; Schwaiger, M, 1999) |
| "The diagnosis of multiple myeloma with mandibular involvement was confirmed by bone marrow examination." | 1.30 | Mandibular mass as the presenting manifestation of IgM myeloma in a 22-year-old man. ( Chao, TY; Chen, YC; Ho, CL; Kao, WY; Yiang, YT, 1999) |
| "We present a case of primary plasma cell leukemia with Bence Jones proteinuria." | 1.29 | Integrin VLA-5 negative primary plasma cell leukemia. ( Amano, K; Aoki, K; Hosono, O; Ito, I; Ito, T; Koide, J; Ohtake, K; Saito, K; Takano, Y; Takeuchi, T, 1993) |
| "In the group with malignant tumors, with liver cirrhosis and with heavy drinkers, the loss of bone volume appears to be considerable in younger individuals but no difference from the controls could be found in older individuals." | 1.27 | [A quantitative morphologic study of cancellous bone--comparative study between physiological and pathological bone loss in autopsy cases]. ( Kameda, N, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagano, S | 1 |
| Mori, M | 1 |
| Kato, A | 1 |
| Ono, Y | 1 |
| Aoki, K | 2 |
| Arima, H | 1 |
| Takiuchi, Y | 1 |
| Tabata, S | 1 |
| Yanagita, S | 1 |
| Matsushita, A | 1 |
| Ishikawa, T | 1 |
| Imai, H | 1 |
| Takahashi, T | 1 |
| Kamal, R | 1 |
| Bansal, SC | 1 |
| Khandelwal, N | 1 |
| Rai, DV | 1 |
| Dhawan, DK | 1 |
| Liu, YC | 1 |
| Chang, WL | 1 |
| Gau, JP | 1 |
| Chao, TC | 1 |
| Gandhi, MM | 1 |
| Nathan, PC | 1 |
| Weitzman, S | 1 |
| Levitt, GA | 1 |
| Yamamoto, Y | 1 |
| Ishii, K | 1 |
| Nomura, S | 1 |
| Fukuhara, S | 1 |
| Terpos, E | 1 |
| Rahemtulla, A | 1 |
| Dimopoulos, MA | 1 |
| Seed, MP | 1 |
| Gardner, CR | 1 |
| Kameda, N | 1 |
| Kaltofen, G | 1 |
| Lindgren, JU | 1 |
| Merchant, CR | 1 |
| DeLuca, HF | 1 |
| Ohtake, K | 1 |
| Takeuchi, T | 1 |
| Saito, K | 1 |
| Ito, T | 1 |
| Ito, I | 1 |
| Takano, Y | 1 |
| Amano, K | 1 |
| Hosono, O | 1 |
| Koide, J | 1 |
| Arnold, W | 1 |
| Kau, R | 1 |
| Schwaiger, M | 1 |
| Ho, CL | 1 |
| Chen, YC | 1 |
| Yiang, YT | 1 |
| Kao, WY | 1 |
| Chao, TY | 1 |
| Thomas, N | 1 |
| Seshadri, MS | 1 |
| Thomas, G | 1 |
| Chacko, R | 1 |
| Samraj, T | 1 |
| Nair, S | 1 |
| Ponnaiya, J | 1 |
| Cherian, T | 1 |
| Stamp, TC | 1 |
| Child, JA | 1 |
| Walker, PG | 1 |
2 reviews available for prednisolone and Osteolysis
| Article | Year |
|---|---|
Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomyc | 2003 |
Current treatment options for myeloma.
Topics: Age Factors; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone | 2005 |
13 other studies available for prednisolone and Osteolysis
| Article | Year |
|---|---|
Therapeutic effects of lenalidomide on hemorrhagic intestinal myeloma-associated AL amyloidosis.
Topics: Aged; Amyloid; Amyloidosis; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Moderate zinc supplementation during prolonged steroid therapy exacerbates bone loss in rats.
Topics: Animals; Bone Density; Calcium; Dietary Supplements; Female; Glucocorticoids; Humans; Osteolysis; Pr | 2014 |
Primary bone lymphoma of the shoulder.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2012 |
[Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposid | 2004 |
The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Azathioprine; Cartilage, Articular; Cyclospo | 2005 |
[A quantitative morphologic study of cancellous bone--comparative study between physiological and pathological bone loss in autopsy cases].
Topics: Adolescent; Adult; Aged; Aging; Alcoholism; Bone Resorption; Child; Diabetes Complications; Female; | 1984 |
[Diagnosis and therapy of micromolecular plasmocytomas -- a case report].
Topics: Bence Jones Protein; Humans; Immunoglobulin kappa-Chains; Lumbar Vertebrae; Male; Melphalan; Middle | 1980 |
Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats.
Topics: Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Femur; Intestinal Absorption; Male; O | 1982 |
Integrin VLA-5 negative primary plasma cell leukemia.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Aged; Antigens, CD; Antigens, Differentiation; Antigens, | 1993 |
[Clinical aspects of the osteolytic (inflammatory) phase of cochlear otosclerosis].
Topics: Adult; Anti-Inflammatory Agents; Auditory Threshold; Bone Regeneration; Cochlea; Deafness; Diagnosti | 1999 |
Mandibular mass as the presenting manifestation of IgM myeloma in a 22-year-old man.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Immunoglob | 1999 |
Association of central giant-cell granuloma of the maxilla with pyknodysostosis.
Topics: Adolescent; Anti-Inflammatory Agents; Dwarfism; Dysostoses; Female; Fingers; Fractures, Bone; Glucoc | 2000 |
Treatment of osteolytic myelomatosis with mithramycin.
Topics: Aged; Calcium; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Injection | 1975 |